Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network
Alzheimer’s disease (AD), the most common type of dementia, is a progressive disease beginning with mild memory loss, possibly leading to loss of the ability to carry on a conversation and respond to environments. It can seriously affect a person’s ability to carry out daily activities. Therefore, e...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ef23e82ff19944889342ed459fd053fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ef23e82ff19944889342ed459fd053fc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ef23e82ff19944889342ed459fd053fc2021-11-25T18:58:06ZDiagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network10.3390/s212276341424-8220https://doaj.org/article/ef23e82ff19944889342ed459fd053fc2021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8220/21/22/7634https://doaj.org/toc/1424-8220Alzheimer’s disease (AD), the most common type of dementia, is a progressive disease beginning with mild memory loss, possibly leading to loss of the ability to carry on a conversation and respond to environments. It can seriously affect a person’s ability to carry out daily activities. Therefore, early diagnosis of AD is conducive to better treatment and avoiding further deterioration of the disease. Magnetic resonance imaging (MRI) has become the main tool for humans to study brain tissues. It can clearly reflect the internal structure of a brain and plays an important role in the diagnosis of Alzheimer’s disease. MRI data is widely used for disease diagnosis. In this paper, based on MRI data, a method combining a 3D convolutional neural network and ensemble learning is proposed to improve the diagnosis accuracy. Then, a data denoising module is proposed to reduce boundary noise. The experimental results on ADNI dataset demonstrate that the model proposed in this paper improves the training speed of the neural network and achieves 95.2% accuracy in AD vs. NC (normal control) task and 77.8% accuracy in sMCI (stable mild cognitive impairment) vs. pMCI (progressive mild cognitive impairment) task in the diagnosis of Alzheimer’s disease.Peng ZhangShukuan LinJianzhong QiaoYue TuMDPI AGarticleAlzheimer’s diseaseconvolutional neural networkensemble learningdata denoisingChemical technologyTP1-1185ENSensors, Vol 21, Iss 7634, p 7634 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Alzheimer’s disease convolutional neural network ensemble learning data denoising Chemical technology TP1-1185 |
spellingShingle |
Alzheimer’s disease convolutional neural network ensemble learning data denoising Chemical technology TP1-1185 Peng Zhang Shukuan Lin Jianzhong Qiao Yue Tu Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network |
description |
Alzheimer’s disease (AD), the most common type of dementia, is a progressive disease beginning with mild memory loss, possibly leading to loss of the ability to carry on a conversation and respond to environments. It can seriously affect a person’s ability to carry out daily activities. Therefore, early diagnosis of AD is conducive to better treatment and avoiding further deterioration of the disease. Magnetic resonance imaging (MRI) has become the main tool for humans to study brain tissues. It can clearly reflect the internal structure of a brain and plays an important role in the diagnosis of Alzheimer’s disease. MRI data is widely used for disease diagnosis. In this paper, based on MRI data, a method combining a 3D convolutional neural network and ensemble learning is proposed to improve the diagnosis accuracy. Then, a data denoising module is proposed to reduce boundary noise. The experimental results on ADNI dataset demonstrate that the model proposed in this paper improves the training speed of the neural network and achieves 95.2% accuracy in AD vs. NC (normal control) task and 77.8% accuracy in sMCI (stable mild cognitive impairment) vs. pMCI (progressive mild cognitive impairment) task in the diagnosis of Alzheimer’s disease. |
format |
article |
author |
Peng Zhang Shukuan Lin Jianzhong Qiao Yue Tu |
author_facet |
Peng Zhang Shukuan Lin Jianzhong Qiao Yue Tu |
author_sort |
Peng Zhang |
title |
Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network |
title_short |
Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network |
title_full |
Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network |
title_fullStr |
Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network |
title_full_unstemmed |
Diagnosis of Alzheimer’s Disease with Ensemble Learning Classifier and 3D Convolutional Neural Network |
title_sort |
diagnosis of alzheimer’s disease with ensemble learning classifier and 3d convolutional neural network |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/ef23e82ff19944889342ed459fd053fc |
work_keys_str_mv |
AT pengzhang diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork AT shukuanlin diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork AT jianzhongqiao diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork AT yuetu diagnosisofalzheimersdiseasewithensemblelearningclassifierand3dconvolutionalneuralnetwork |
_version_ |
1718410499654156288 |